Gyre Therapeutics (GYRE) Cash & Equivalents (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.75% |
| Dec 31, 2025 | -38.43% |
| Sep 30, 2025 | 41.04% |
| Jun 30, 2025 | 677.13% |
| Mar 31, 2025 | -68.76% |
| Dec 31, 2024 | -25.63% |
| Sep 30, 2024 | -1.45% |
| Jun 30, 2024 | 85.40% |
| Mar 31, 2024 | -74.08% |
| Dec 31, 2023 | 1,423.14% |
| Sep 30, 2023 | -80.92% |
| Jun 30, 2023 | -8.85% |
| Mar 31, 2023 | -49.76% |
| Dec 31, 2022 | 8.98% |
| Sep 30, 2022 | -69.36% |
| Jun 30, 2022 | 116.54% |
| Mar 31, 2022 | -21.49% |
| Dec 31, 2021 | -25.04% |
| Sep 30, 2021 | -19.65% |
| Jun 30, 2021 | -31.20% |
| Mar 31, 2021 | 30.65% |
| Dec 31, 2020 | 228.60% |
| Sep 30, 2020 | -57.95% |
| Jun 30, 2020 | -15.76% |
| Mar 31, 2020 | -8.46% |
| Dec 31, 2019 | -9.57% |
| Sep 30, 2019 | 389.97% |
| Jun 30, 2019 | -30.67% |
| Mar 31, 2019 | -78.98% |
| Dec 31, 2018 | 230.72% |
| Sep 30, 2018 | -22.64% |
| Jun 30, 2018 | -63.23% |
| Mar 31, 2018 | 236.23% |
| Dec 31, 2017 | 243.01% |
| Sep 30, 2017 | -66.12% |
| Jun 30, 2017 | 122.86% |
| Mar 31, 2017 | 41.59% |
| Dec 31, 2016 | 10.16% |
| Sep 30, 2016 | -17.79% |
| Jun 30, 2016 | -44.93% |
| Mar 31, 2016 | -29.27% |
| Dec 31, 2015 | 25.98% |
| Sep 30, 2015 | 901.56% |
| Jun 30, 2015 | 11.45% |
| Mar 31, 2015 | 34.00% |
| Dec 31, 2014 | -57.15% |
| Sep 30, 2014 | -91.70% |
| Jun 30, 2014 | -3.61% |
| Mar 31, 2014 | 1,492.68% |
| Dec 31, 2013 | -95.42% |
| Sep 30, 2013 | -2.09% |
| Jun 30, 2013 | -9.74% |
| Mar 31, 2013 | 1,954.13% |
| Dec 31, 2012 | -95.65% |
| Sep 30, 2012 | 9.15% |
| Jun 30, 2012 | -19.20% |
| Mar 31, 2012 | -17.35% |
| Dec 31, 2011 | -17.82% |
| Sep 30, 2011 | -22.36% |
| Jun 30, 2011 | 21.11% |
| Mar 31, 2011 | -16.29% |
| Dec 31, 2010 | -10.73% |
| Sep 30, 2010 | -16.17% |